Table 1.
The prevalence of HPV and genotypes distribution among Hani and Han ethnic women.
| Variables | Total (n 1 = 396) | Hani (n 1 = 237) | Han (n 1 = 159) | P value2 | |||
|---|---|---|---|---|---|---|---|
| Positive | P% (95% CI)3 | Positive | P% (95% CI)3 | Positive | P% (95% CI)3 | ||
| Age | 41.67 ± 7.62 (40.92–42.42) | 41.58 ± 8.99 (40.43–42.73) | 41.81 ± 4.91 (41.04–42.58) | 0.76 | |||
| Prevalence | 70 | 17.68 (13.93–21.44) | 50 | 21.1 (15.91–26.29) | 20 | 12.6 (7.45–17.75) | 0.032 |
| Single infection | 52 | 13.13 (9.8–16.46) | 38 | 15.6 (11.4–20.22) | 14 | 9.4 (5.06–14.14) | 0.016 |
| High risk | 38 | 9.6 (6.7–12.5) | 26 | 11 (7.01–14.98) | 13 | 8.2 (4.94–12.46) | 0.39 |
| HPV-16 | 14 | 3.53 (1.71–5.35) | 9 | 3.8 (2.56–5.04) | 5 | 3.1 (0.41–6.09) | 0.73 |
| HPV-52 | 6 | 1.51 (0.31–2.71) | 4 | 1.69 (0.06–3.34) | 2 | 1.3 | 1.000 |
| HPV-68 | 2 | 0.50 | 1 | 0.42 | 1 | 0.63 | 1.000 |
| HPV-33 | 3 | 0.76 | 2 | 0.84 | 1 | 0.63 | 1.000 |
| HPV-31 | 2 | 0.50 | 2 | 0.84 | 0 | — | — |
| HPV-18 | 2 | 0.50 | 1 | 0.42 | 1 | 0.63 | 1.000 |
| HPV-58 | 2 | 0.50 | 1 | 0.42 | 1 | 0.63 | 1.000 |
| HPV-35 | 1 | 0.25 | 1 | 0.42 | 0 | — | — |
| HPV-59 | 1 | 0.25 | 1 | 0.42 | 0 | — | — |
| HPV-53 | 1 | 0.25 | 1 | 0.42 | 0 | — | — |
| HPV-51 | 1 | 0.25 | 1 | 0.42 | 0 | — | — |
| HPV-56 | 2 | 0.50 | 1 | 0.42 | 1 | 0.63 | 1.000 |
| HPV-66 | 1 | 0.25 | 1 | 0.42 | 0 | — | — |
| HPV-83 | 1 | 0.25 | 0 | — | 1 | 0.63 | — |
| Low risk | 14 | 3.53 (1.71–5.35) | 11 | 4.6 (1.93–7.27) | 2 | 1.26 (0.47–2.99) | 0.084 |
| HPV-54 | 3 | 0.76 | 2 | 0.84 | 1 | 0.63 | 1.000 |
| HPV-55 | 2 | 0.50 | 2 | 0.84 | 0 | — | — |
| HPV-11 | 3 | 0.76 | 3 | 1.26 | 0 | — | — |
| HPV-42 | 2 | 0.50 | 2 | 0.84 | 0 | — | — |
| HPV-40 | 1 | 0.25 | 1 | 0.42 | 0 | — | — |
| HPV-43 | 1 | 0.25 | 1 | 0.42 | 0 | — | — |
| HPV-44 | 1 | 0.25 | 0 | — | 1 | 0.63 | — |
| Multiple infection | 18 | 4.54 (2.49–6.59) | 13 | 5.5 (2.6–8.4) | 5 | 3.2 (0.47–5.93) | 0.33 |
| Double infection | 14 | 3.53 (1.71–5.35) | 10 | 4.2 (1.65–6.75) | 4 | 2.5 (0.08–4.93) | 0.42 |
| High risk | 8 | 2.02 (0.64–3.4) | 5 | 2.1 (0.28–3.92) | 3 | 1.9 (0.81–2.99) | 1.000 |
| HPV-16/58 | 1 | 0.25 | 1 | 0.42 | 0 | — | — |
| HPV-16/52 | 1 | 0.25 | 1 | 0.42 | 0 | — | — |
| HPV-39/68 | 1 | 0.25 | 1 | 0.42 | 0 | — | — |
| HPV-52/58 | 1 | 0.25 | 1 | 0.42 | 0 | — | — |
| HPV-18/68 | 1 | 0.25 | 1 | 0.42 | 0 | — | — |
| HPV-16/33 | 1 | 0.25 | 0 | — | 1 | 0.63 | — |
| HPV-18/58 | 1 | 0.25 | 0 | — | 1 | 0.63 | — |
| HPV-52/66 | 1 | 0.25 | 0 | — | 1 | 0.63 | — |
| Mixed infection | 5 | 1.26 (0.16–2.36) | 4 | 1.7 (0.06–3.34) | 1 | 0.63 (−0.6–1.86) | 0.65 |
| HPV-56/43 | 1 | 0.25 | 0 | — | 1 | 0.63 | — |
| HPV-58/6 | 1 | 0.25 | 1 | 0.42 | 0 | — | — |
| HPV-52/6 | 1 | 0.25 | 1 | 0.42 | 0 | — | — |
| HPV-52/43 | 1 | 0.25 | 1 | 0.42 | 0 | — | — |
| HPV-51/54 | 1 | 0.25 | 1 | 0.42 | 0 | — | — |
| Low risk | 1 | 0.25 | 1 | 0.42 | 0 | — | — |
| HPV-54/55 | 1 | 0.25 | 1 | 0.42 | 0 | — | — |
| Triple infection | 4 | 1.01 (0.03–1.99) | 3 | 1.3 (0.014–2.74) | 1 | 0.63 (−0.6–1.86) | 0.65 |
| High risk | 2 | 0.50 | 1 | 0.42 | 1 | 0.63 (−0.6–1.86) | |
| HPV-33/35/58 | 1 | 0.25 | 1 | 0.42 | 0 | — | — |
| HPV-16/31/52 | 1 | 0.25 | 0 | — | 1 | 0.63 | — |
| Mixed infection | 2 | 0.50 | 2 | 0.84 | 0 | — | — |
|
| |||||||
| HPV-16/58/44 | 1 | 0.25 | 1 | 0.42 | 0 | — | — |
1Total number of participants.
2The HPV prevalence values between the Han and Hani women were compared using the Chi-square test. Bold type indicates statistically significant values.
3Percent of positivity (P%) and 95% confidence interval (CI) obtained by using the binomial distribution analysis model.